FARMER'S MARKET Group

For patients with "Ski-Slope" hearing loss—where they can hear low frequencies but are deaf to high frequencies—2026 offers Electro-Acoustic Stimulation (EAS). This hybrid technology combines a hearing aid and a cochlear implant in a single device.

The acoustic component amplifies natural low-frequency sounds, while the bionic component provides electrical stimulation for the high frequencies. This dual approach provides a much "richer" sound quality, making it significantly easier for users to enjoy music and appreciate the subtle nuances of melody and timbre that were previously lost with electrical-only stimulation.

One of the most popular delivery methods in 2026 is the Bioidentical Hormone Pellet. These are rice-sized cylinders inserted under the skin (usually in the hip area) that provide a consistent release of hormones over 3 to 6 months.

Pellets bypass the "peaks and valleys" associated with creams or oral medications. Because the hormones are released directly into the bloodstream based on cardiac output, the body receives more hormone during exercise and less during rest. This "auto-regulating" feature mimics the natural secretory patterns of the human endocrine system more closely than any other delivery method.

The Italian Federation of Centers for the Surveillance of Anticoagulant Therapies (FCSA) remains the backbone of the country’s high safety standards. Italy boasts a network of over 300 specialized Thrombosis Centers that provide:

• Standardized Quality: Italy maintains one of the highest "Time in Therapeutic Range" (TTR) averages globally for patients still on VKAs (Warfarin).

• Education Hubs: Centers provide mandatory patient education modules, focusing on dietary consistency and the "Rule of Three" (dose, timing, and symptoms).

• Emergency Reversal Protocols: These centers act as the primary nodes for administering specific reversal agents in trauma or urgent surgery cases.